The Timing and Probability of Switching to Second-line Regimen - An application to Second-Line Antiretroviral Therapy in India

Felipa De Mello-Sampayo

MPRA Paper from University Library of Munich, Germany

Abstract: Health fluctuations render the outcome of any treatment switch uncertain, so that decision makers might have to wait for more information before optimally switching treatments. This paper sets up a stochastic model that provides an optimal rule for the timing of treatment switch. The results of the model were then tested empirically with patient-based data on first-line and second-line antiretroviral treatment in India. The empirical results support the findings of the analytical model.

Keywords: Uncertainty; Utility Function; Health; Antiretroviral Treatment; Treatment Switch (search for similar items in EconPapers)
JEL-codes: C61 D81 I18 (search for similar items in EconPapers)
Date: 2014-12-29
New Economics Papers: this item is included in nep-hea and nep-upt
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/60997/1/MPRA_paper_60997.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:60997

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().